Clinical trial Recruiting at 2 sites Interventional

Using CO2 Insufflation During Laparoscopy to Treat Premature Infants with Severe Intestinal Inflammation

Official title: Study of the Influence of Intraperitoneal Insufflation of Carbon Dioxide (CO2) by Laparoscopy on the Short-term Evolution of Premature Infants With Ulcerative Necrotizing Enterocolitis

Run by Assistance Publique - Hôpitaux de Paris · NCT05882448 · Data updated 2026-11-12

This study is testing if a combination of two types of surgery can help premature infants with severe intestinal inflammation feel better and recover more effectively than just one type of surgery.

Quick facts

Study typeInterventional
SexAll
Enrollment54 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedFebruary 22, 2024
Main results expectedJune 22, 2025
Study endsSeptember 22, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT05882448 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premature newborns under 37 weeks of gestation diagnosed with complicated ECUN requiring surgical intervention.

Probably not a fit

Patients with isolated small intestine perforation or those unstable for surgery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot trial evaluates the effectiveness of laparoscopic surgery combined with laparotomy in treating premature infants suffering from ulcerative necrotizing enterocolitis (ECUN). The study involves a multicenter randomized controlled design where infants are assigned to either receive both laparoscopic and laparotomy procedures or laparotomy alone. The primary focus is on measuring the inflammatory response through blood C-reactive protein levels post-surgery. Secondary objectives include assessing various postoperative outcomes such as mortality, bowel morbidity, and neurological impacts.

Why it matters

Potential benefit: If successful, this approach could significantly reduce inflammation and improve recovery outcomes for premature infants with ECUN.

How similar studies have gone: While the specific use of CO2 insufflation in this context is novel, similar approaches in managing inflammation during surgery have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premature newborn (term of birth: \<37 weeks of amenorrhea)
* Diagnosis of ECUN by the surgeon (distension abdominal +/- rectal bleeding +/- green gastric residue, increased biological inflammatory syndrome, + pneumatosis on abdominal radiography)
* Hospitalized and complicated ECUN: presenting either a pneumoperitoneum on abdominal X-ray or a absence of clinical and biological improvement after 48 hours of maximum well-conducted medical treatment (IV antibiotic therapy and digestive rest).
* Hospitalized in the 2 participating centers
* Of which the 2 holders of parental authority have been informed and have signed the consent form
* Having social security coverage (social security or CMU)

Exclusion Criteria:

* Instability contraindicating movement to the operating room or contraindicating CO2 insufflation
* Diagnosis of isolated perforation of the small intestine (radiography:

pneumoperitoneum without pneumatosis)

Where it's running

  • Hôpital Armand Trousseau Service de Chirurgie Pédiatrique et Néonatale
    Paris, France
    Recruiting
  • Hôpital Robert Debré Service de Chirurgie Pédiatrique
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.